Status:
UNKNOWN
Incidence of Hepatitis B Virus (HBV) Reactivation in HBsAg Negative/HBcAb Positive Lymphoma Patients Treated With RCHOP
Lead Sponsor:
Fudan University
Conditions:
Lymphoma
Eligibility:
All Genders
18-75 years
Phase:
PHASE2
PHASE3
Brief Summary
The aim of this study is to identify the incidence of hepatitis B virus reactivation rate in Diffuse Large B Cell or high grade Follicular lymphoma patients with prior resolved hepatitis B undergoing ...
Eligibility Criteria
Inclusion
- Naive DLBCL or high grade FL patients
- Age range 18-75 years old
- ECOG performance status 0-3
- Life expectancy of more than 3 months
- Adequate organ function
- HBsAg negative/HBcAb positive at baseline
Exclusion
- Infection of HAV,HCV,HIV
- Pregnant or lactating women
- Serious uncontrolled diseases
Key Trial Info
Start Date :
October 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2014
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT01210287
Start Date
October 1 2010
End Date
August 1 2014
Last Update
January 8 2014
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, China, 200032
2
Fudan University Cancer Hospital
Shanghai, Shanghai Municipality, China, 86-21